Intelligence · Clinical Development
Pipeline search results
Programs matching “schizophrenia” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 97 pipeline programs matching "schizophrenia" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
LY03010/CT-EUR-102
Lacuna Pharma Pty Ltd
Schizophrenia
1 trial -
Motivational Interviewing
BRIGHT MINDS BIOSCIENCES INC.
Schizophrenia
1 trial -
Olanzapine Extended Release
Teva Pharma GmbH
Schizophrenia, Schizoaffective Disorder
1 trial -
Risperidone
The First People's Hospital of Lianyungang
Schizophrenia
1 trial -
Roflumilast
Takeda
Schizophrenia
1 trial -
SPD489 (Lisdexamfetamine dimesylate)
Takeda
Schizophrenia
1 trial -
TAK-058
Takeda
Schizophrenia
1 trial -
TAK-063
Takeda
Schizophrenia
1 trial -
TAK-831 Oral Suspension
NEUROCRINE BIOSCIENCES INC
Schizophrenia, Cerebellar Ataxia
1 trial -
TV44749-BA-10196
Lacuna Pharma Pty Ltd
Schizophrenia
1 trial -
VHX-896 and iloperidone
Vanda Pharmaceuticals Netherlands B.V.
Schizophrenia
1 trial -
Aripiprazole
Otsuka Beijing Research Institute
Schizophrenia
3 trials -
Clozapine
BRIGHT MINDS BIOSCIENCES INC.
Schizophrenia
1 trial -
Dexmedetomidine
BioXcel Therapeutics
Schizophrenia Agitation
1 trial -
INTENSIFY SZ
Disc Medicine
schizophrenia, schizoaffective disorder, schizophrenifom disorder
1 trial -
Iloperidone
Vanda Pharmaceuticals Netherlands B.V.
Schizophrenia
5 trials -
Minocycline
BRIGHT MINDS BIOSCIENCES INC.
Schizophrenia
1 trial -
PERSERIS
Indivior Pty Ltd
Schizophrenia
1 trial -
Paliperidone ER
Hospital Authority, Hong Kong
Schizophrenia
1 trial -
Ramelteon
Takeda
Schizophrenia
1 trial -
Valbenazine
NEUROCRINE BIOSCIENCES INC
Schizophrenia
3 trials -
Varenicline
BRIGHT MINDS BIOSCIENCES INC.
Schizophrenia
2 trials -
Vortioxetine
Takeda
Schizophrenia
1 trial -
Olanzapine
Guangzhou Psychiatric Hospital
Schizophrenia
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.